NCT03004703 ASSessing the Effect of Anti-IL-6 Treatment in Myocardial Infarction: The ASSAIL-MI Trial Status COMPLETED Phase PHASE2
NCT02997956 Study of Tocilizumab in Patients With Hepatocellular Carcinoma (HCC) Undergoing Transarterial Chemoembolization (TACE) Status WITHDRAWN Phase PHASE1/PHASE2
NCT02963402 Immunoregulatory Mechanisms of Treg Cells Induced by Tocilizumab Status COMPLETED Phase N/A
NCT02929251 Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis Status COMPLETED Phase PHASE2
NCT02908217 Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE Status COMPLETED Phase PHASE3
NCT02906371 Study of the Tocilizumab Optimization Timing for CART19 Associated Cytokine Release Syndrome Status COMPLETED Phase PHASE1
NCT02888496 Lymphocyte and Cytokine Disturbances in Polymyalgia Rheumatica Status COMPLETED Phase N/A
NCT02843789 Evolution of Adipokines and Body Composition in Rheumatoid Arthritis Patients Receiving Tocilizumab Therapy Status COMPLETED Phase PHASE4
NCT02809833 Use of Tocilizumab for Rheumatoid Arthritis (RA) in Daily Routine Status COMPLETED Phase N/A
NCT02797769 A Time to Cardiovascular Event Analysis Comparing Tocilizumab to Other Biologics in Patients With Rheumatoid Arthritis (RA) Status COMPLETED Phase N/A
NCT02778789 Comparing the Efficacy of Periarticular Bone Structure in Patients Treated With Either Tocilizumab or Tumor Necrosis Factor Blockers Status COMPLETED Phase N/A
NCT02767557 Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab in Pancreatic Cancer Patients Status COMPLETED Phase PHASE2
NCT02735707 Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia Status RECRUITING Phase PHASE3
NCT02721004 Efficacy and Safety Study of RoActemra (Tocilizumab) in Participants With Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT02682823 Tocilizumab Real-Life Human Factors (RLHFs) Validation Study Status COMPLETED Phase PHASE4
NCT02678988 A Study to Evaluate the Bioequivalence of Tocilizumab Following Subcutaneous Administration Via an Autoinjector (AI 1000-G2) Versus a Pre-Filled Syringe in Healthy Volunteers Status COMPLETED Phase PHASE1